Heart artery showdown: which technique wins?

NCT ID NCT06878729

Recruiting now Knowledge-focused Sponsor: National Institute of Cardiology, Warsaw, Poland Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two methods for opening completely blocked heart arteries: antegrade dissection and re-entry (ADR) versus a retrograde approach. Researchers will measure procedure time, success rates, complications, and even doctor stress levels. 74 participants with difficult blockages will be randomly assigned to one technique.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors choose the best technique for opening blocked heart arteries, improving success and reducing complications.
What could go wrong: This is a small, early-stage study (74 people) comparing two established procedures, so it may not lead to major changes in practice. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Occlusion coronary stenosis coronary thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE CORONARY OCCLUSION PERCUTANEOUS CORONARY INTERVENTION

Contacts and locations

Locations

1st Military Clinical Hospital
RECRUITING

Lublin, Poland
Hospital of the Ministry of the Interior and Administration
RECRUITING

Lublin, Poland
National Institute of Cardiology
RECRUITING

Warsaw, Warsaw, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.